Cell death in irradiated prostate epithelial cells: Role of apoptotic and clonogenic cell kill

Prostate Cancer and Prostatic Diseases

Volumn 6, Issue 1, 2003, Pages 73-85

  Bromfield, G P ^b   Meng, A ^b   Warde, P ^a   Bristow, Rob ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apoptosis; Epithelium; Prostate cancer; Radiosensitivity; Senescence

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P16; PROTEIN P21; PROTEIN P53; SURVIVIN;

APOPTOSIS; ATTENUATION; CANCER CELL CULTURE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CELL AGING; CELL CLONING; CELL CYCLE G1 PHASE; CELL DEATH; CELL KILLING; CELL PROLIFERATION; CELL STRUCTURE; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IONIZING RADIATION; MALE; MITOSIS INHIBITION; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOSENSITIVITY; REVIEW; STROMA CELL;

APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; EPITHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RADIOTHERAPY, CONFORMAL; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY;

EID: 0037248566     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500628     Document Type: Review

References (59)

1. Lukka H et al. Controversies in prostate cancer radiotherapy: consensus development. Can J Urol 2001; 8: 1314-1322.
2. Dearnaley DP. Radiotherapy and combined modality approaches in localised prostate cancer. Eur J Cancer 2001; 37: S137-145.
3. Bristow RG, Hill P. Molecular and cellular basis of radiotherapy In: Tannock IF and Hill RP (eds). The Basic Science of Oncology. McGraw-Hill: Toronto, 1998, pp 295-321.
4. Wong CS, Hill RP. Experimental Radiotherapy In: Tannock IF and Hill RP (eds). The Basic Science of Oncology, 3rd edn. McGraw-Hill: Toronto, 1998, pp 322-349.
5. Sandford NL, Searle JW, Kerr JF. Successive waves of apoptosis in the rat prostate alter repeated withdrawal of testosterone stimulation. Pathology 1984; 16: 400-410.
6. Kyprianou N, Issacs JT. Expression of transforming growth factor-beta in rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 1989; 3: 1515-1522.
7. Bruckheimer EM et al. The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo. Oncogene 2000; 19: 2404-2412.
8. Westin P, Stattin P, Darnber JE, Bergh A. Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am J Pathol 1995; 146: 1368-1375.
9. Rakozy C et al. Expression of bcl-2, p53, and p21 in benign and malignant prostatic tissue before and after radiation therapy. Mod Pathol 1998; 11: 892-899.
10. Grossfeld GD et al. Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity. J Urol 1998; 159: 1437-1443.
11. Bristow RG, Benchimol S, Hill RP. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 1996; 40: 197-223.
12. Bristow RG, Benchimol S, Hill R. p53 protein expression or protein function? Int J Radiat Oncol Biol Phys 1996; 35: 1123-1125.
13. Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33: 781-796.
14. Olive PL, Vikse CM, Vanderbyl S. Increase in the fraction of necrotic, not apoptotic, cells in SiHa xenograft tumours shortly after irradiation. Radiother Oncol 1999; 50: 113-119.
15. Stephens LC et al. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res 1993; 135: 75-80.
16. Tannock IF, Lee C. Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br J Cancer 2001; 84: 100-105.
17. Schwarze SR et al. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells. Oncogene 2001; 20: 8184-8192.
18. Stein GH, Drullinger LF, Soulard A, Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 1999; 19: 2109-2117.
19. Chang BD et al. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 1999; 59: 3761-3767.
20. Lyons AB, Hasbold J, Hodgkin PD. Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. Meth Cell Biol 2001; 63: 375-398.
21. Soucie EL et al. Myc protentiates apoptosis by stimulating Bax activity at the mitochondria. Mol Cell Biol 2001; 21: 4725-4736.
22. Garzotto M et al. Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase. Cancer Res 1999; 59: 5194-5201.
23. Pollack A et al. Lack of prostate cancer radiosensitization by androgen deprivation. Int J Radiat Oncol Biol Phys 2001; 51: 1002-1007.
24. Bristow RG et al. Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation. Oncogene 1998; 16: 1789-1802.
25. Lee ST et al. Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts. Oncogene 1999; 18: 3520-3528.
26. Kurts C et al. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997; 186: 239-245.
27. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7: 542-547.
28. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-921.
29. Slingerland JM, Tannock IF. Cell proliferation and cell death In: Tannock IF, Hill RP. (eds). The Basic Science of Oncology, 3rd ed. McGraw-Hill: Toronto, 1998, pp 134-165.
30. Kaufmann SH et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-3985.
31. Winter RN, Kramer A, Borkowski A, Kyprianou N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 2001; 61: 1227-1232.
32. Olive PL. DNA damage and repair in individual cells: applications of the comet assay in radiobiology. Int J Radiat Biol 1999; 75: 395-405.
33. Wahl GM, Carr AM. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat Cell Biol 2001; 3: E277-286.
34. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998; 12: 2973-2983.
35. Carroll AG, Voeller HJ, Sugars L, Gelmann EP. p53 oncogene mutations in three human prostate cancer cell lines. Prostate 1993; 23: 123-134.
36. Girinsky T et al. Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res 1995; 55: 3726-3731.
37. Krtolica A et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001; 98: 12072-12077.
38. Leith JT. In vitro radiation sensitivity of the LNCaP prostatic tumor cell line. Prostate 1994; 24: 119-124.
39. DeWeese TL, Shipman JM, Dillehay LE, Nelson WG. Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. J Urol 1998; 159: 591-598.
40. Suzuki K et al. Radiation-induced senescence-like growth arrest requires TP53 function but not telomere shortening. Radiat Res 2001; 155: 248-253.
41. Rave-Frank M et al. In vitro response of human dermal fibroblasts to X-irradiation: relationship between radiation-induced clonogenic cell death, chromosome aberrations and markers of proliferative senescence or differentiation. Int J Radiat Biol 2001; 77: 1163-1174.
42. Kamijo T et al. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. Cancer Res 1999; 59: 2464-2469.
43. Chang BD et al. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci USA 2002; 99: 389-394.
44. Kyprianou N, King ED, Bradbury D, Rhee JG. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer 1997; 70: 341-348.
45. Sheridan MT, West CM. Ability to undergo apoptosis does not correlate with the intrinsic radiosensitivity (SF2) of human cervix tumor cell lines. Int J Radiat Oncol Biol Phys 2001; 50: 503-509.
46. Lock RB, Stribinskiene L. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 1996; 56: 4006-4012.
47. Aldridge DR, Arends MJ, Radford IR. Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose-response. Br J Cancer 1995; 71: 571-577.
48. Meyer KM, Hess SM, Tlsty TD, Leadon SA. Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light. Oncogene 1999; 18: 5795-5805.
49. Romanov SR et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001; 409: 633-637.
50. Kabalin JN, Peehl DM, Stamey TA. Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate 1989; 14: 251-263.
51. Camps JL et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA 1990; 87: 75-79.
52. Kao GD, McKenna WG, Yen TJ. Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells. Oncogene 2001; 20: 3486-3496.
53. Hwang A, Muschel RJ. Radiation and the G2 phase of the cell cycle. Radiat Res 1998; 150: S52-59.
54. Gaudin PB et al. Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol 1999; 23: 1021-1031.
55. Pollack A et al. The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions. Int J Radiat Oncol Biol Phys 2000; 46: 153-158.
56. Bolla, M et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. New Engl J Med 1997; 337: 295-300.
57. Crook J et al. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 2000; 48: 355-367.
58. Suenaga M et al. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Int J Cancer 2002; 97: 621-625.
59. Marks PA, Rifkind RA, Richon VM, Breslow R. Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin Cancer Res 2001; 7: 759-760.